2,425
Views
4
CrossRef citations to date
0
Altmetric
Articles

Biologic treatment for psoriasis in cancer patients: should they still be considered forbidden?

ORCID Icon, , , , , , , & ORCID Icon show all
Pages 2495-2502 | Received 31 Jul 2021, Accepted 12 Aug 2021, Published online: 30 Aug 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Lluís Rusiñol, Gemma Camiña-Conforto & Luis Puig. (2022) Biologic treatment of psoriasis in oncologic patients. Expert Opinion on Biological Therapy 22:12, pages 1567-1578.
Read now

Articles from other publishers (3)

Kim A. Papp, Barbara Melosky, Sandeep Sehdev, Sebastien J. Hotte, Jennifer R. Beecker, Mark G. Kirchhof, Irina Turchin, Jan P. Dutz, Melinda J. Gooderham, Robert Gniadecki, Chih-ho Hong, Jo Lambert, Charles W. Lynde, Vimal H. Prajapati & Ronald B. Vender. (2023) Use of Systemic Therapies for Treatment of Psoriasis in Patients with a History of Treated Solid Tumours: Inference-Based Guidance from a Multidisciplinary Expert Panel. Dermatology and Therapy 13:4, pages 867-889.
Crossref
Pedro Rodríguez‐Jiménez, Ander Mayor Ibarguren, Beatriz Butrón‐Bris, Luisa Martos‐Cabrera & Mar Llamas‐Velasco. (2023) Can we treat anti‐PD1 induced psoriasis in patients with active cancer with biologic therapy? Report of three cases. JEADV Clinical Practice.
Crossref
Cristina Pellegrini, Maria Esposito, Ernesto Rossi, Paolo Gisondi, Stefano Piaserico, Paolo Dapavo, Andrea Conti, Alessio Gambardella, Martina Burlando, Alessandra Narcisi, Annamaria Offidani, Riccardo Balestri, Federico Bardazzi, Francesca Prignano, Cristina Mugheddu, Marco Romanelli, Giovanna Malara, Giovanni Schinzari & Maria Concetta Fargnoli. (2022) Secukinumab in Patients with Psoriasis and a Personal History of Malignancy: A Multicenter Real-Life Observational Study. Dermatology and Therapy 12:11, pages 2613-2626.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.